MR编号 | HU/H/0882/003 |
---|
药品名称 | Nilotinib STADA 200 mg hard capsule |
---|
活性成分 | |
---|
剂型 | Capsule, hard |
---|
上市许可持有人 | STADA Arzneimittel AG
Stadastrasse 2-18
61118 Bad Vilbel
Germany
Thesi Loggos Industrial Zone
Metamorfossi
144 52 Greece
Telephone +30 2106664667
E-mail info@pharosgr.gr |
---|
参考成员国 - 产品名称 | Hungary (HU) |
---|
互认成员国 - 产品名称 | - Malta (MT)
- Belgium (BE)
- Norway (NO)
- Croatia (HR)
- Netherlands (NL)
Nilotinib PharOS 200 mg, capsule, hard - Finland (FI)
- Luxembourg (LU)
- Poland (PL)
Nilotinib STADA - Iceland (IS)
- Latvia (LV)
- Ireland (IE)
- Lithuania (LT)
Nilotinib PharOS 200 mg kietosios kapsulės - Austria (AT)
- Estonia (EE)
- France (FR)
- Cyprus (CY)
NILOTINIB/PHAROS 200 mg σκληρό καψάκιο - Spain (ES)
- Czechia (CZ)
Nilotinib PharOS - Portugal (PT)
- Romania (RO)
Nilotinib PharOS 200 mg capsule - Italy (IT)
- Slovakia (SK)
- Germany (DE)
Nilotinib PharOS 200 mg Hartkapseln - Greece (GR)
- Slovenia (SI)
- Denmark (DK)
- Sweden (SE)
|
---|
许可日期 | 2024/05/28 |
---|
最近更新日期 | 2025/01/10 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|